Here you can find our clients' success stories. We are happy to celebrate our client's accomplishments; successful regulatory submissions, funding publications, and more. The largest source of pride comes from the achievements we've helped our clients reach. We've collected some noteworthy client information (from publicly available resources), and we're happy to introduce them here.
AMA approves radiology-specific AI CPT code - The American Medical Association (AMA) has approved a Current Procedural Terminology (CPT) code specific to a radiology artificial intelligence (AI) algorithms.
Alpha Tau Receives Breakthrough Device Designation from the FDA for Alpha DaRT™ - This designation applies to the treatment of Squamous Cell Carcinoma of the skin and oral cavity without a curative standard of care.
Zebra wins FDA clearance for AI-based pleural effusion diagnosis tech. The deep-learning solution automatically identifies findings suggestive of pleural effusion based on CR, DR and DX scans.
HemoScreen™ Hematology Analyzer For Point Of Care, Receives FDA 510(K) Clearance. "The HemoScreen delivers lab accurate results and would be especially useful at physicians' offices, ER, ICU, Oncology clinics and remote locations," says Dr. Bransky.
BrainsWay Receives First Ever FDA Clearance of a Non-Invasive Device for Treatment of Obsessive-Compulsive Disorder. BrainsWay’s deep transcranial magnetic stimulation (Deep TMS) system is a best-in-class device designed to maximize electromagnetic stimulation of deep and broad brain regions, helping to launch a new era in brain disorder treatment.
Oxitone Medical Receives FDA Clearance for Wrist-Sensor Pulse Oximetry Bracelet. Medical device and digital health startup Oxitone Medical launches the first to market wrist-sensor pulse oximetry bracelet to transform delivery of chronic disease home care.